Introduction
============

Azoospermia, which affects \~1% of the male population and may be responsible for up to 20% of male infertility situations, is a medical condition in which the semen contains no sperm ([@b1-etm-0-0-5778]--[@b3-etm-0-0-5778]). Azoospermia may be caused by a lack of spermatozoa production in the testes (secretory or non-obstructive azoospermia; NOA) or due to spermatozoa being unable to reach the ejaculate (excretory or obstructive azoospermia; OA) ([@b1-etm-0-0-5778]). Previous studies have indicated that genetic factors, including chromosomal abnormalities, are responsible for azoospermia; however, few studies have explored the association between microorganisms and azoospermia ([@b1-etm-0-0-5778]--[@b3-etm-0-0-5778]).

Microbiomes in the human skin, intestines, oral cavity, vagina and urethra serve a key role in human health, disease and other etiologies ([@b4-etm-0-0-5778]--[@b6-etm-0-0-5778]). It has been reported that several bacteria, including *Lactobacillus iners*, *Gardnerella vaginalis*, *Escherichia faecalis*, *E. coli* and *Staphylococcus aureus*, are associated with male infertility as demonstrated using polymerase chain reaction (PCR) or culture-based methods ([@b7-etm-0-0-5778]--[@b12-etm-0-0-5778]). However, the majority of previous studies focused on a few types of bacteria and relied on qualitative analysis to discover associations between semen microbiomes and semen quality; as such, at present there is no comprehensive understanding of bacterial communities in semen ([@b13-etm-0-0-5778]).

Recent technological advances in next generation sequencing technology have enabled the pleiotropic effects of microorganisms in the human host to be elucidated, providing an excellent platform to explore the relationship between human and semen microbiota ([@b14-etm-0-0-5778]--[@b20-etm-0-0-5778]). In the present study, the high-throughput sequencing method was used to compare seminal bacterial composition in patients with obstructive and non-obstructive azoospermia. The results may be useful for developing clinical therapies for the prevention and treatment of azoospermia.

Materials and methods
=====================

### Ethical statement

The present study was approved by the Ethical Committee of the Jiangxi Maternal and Child Health Hospital (Nanchang, China) and all participants provided written informed consent. All experiments were carried out in accordance with the guidelines provided by the Jiangxi Maternal and Child Health Hospital.

### Patients and sampling

Samples of seminal plasma were collected at the Jiangxi Maternal and Child Health Hospital between October and December 2016 from three groups of men without leukocytospermia as follows: The control (C) group (22--36 years old), the obstructive azoospermia (OA) group (24--38 years old) and the non-obstructive azoospermia (NOA) group (25--37 years old). A total of 5 fertile donors with normal sperm parameters (seminal volume, 2--6 ml; sperm count, 0.6--1.5×10^12^/l; progressive motile spermatozoa ≥30% or progressive motile spermatozoa + motile spermatozoa ≥50%) ([@b4-etm-0-0-5778]) were recruited as the C group. A total of 12 patients with azoospermia who underwent surgical sperm retrieval via percutaneous epididymal sperm aspiration or testicular sperm extraction were recruited and were divided into the OA group (n=6) and the NOA group (n=6). In OA, sperm are produced normally inside the testicle, but are prevented from reaching the ejaculate due to a blockage or obstruction in the reproductive tubing. In non-obstructive azoospermia group, the tubes are not blocked; however, there is a spermatogenesis problem whereby there is a very low level of sperm production or a total lack of production ([@b8-etm-0-0-5778]). Patients with abnormal karyotypes and those who had previously suffered from an injury to the genitals were excluded.

Prior to sampling, the glans penis of each patient was washed using soap and water. Semen was obtained by masturbation, ejaculated into a sterile collection tube and incubated at 37°C for 30 min for liquefaction. Basic semen parameters and leukocytospermia were detected as previously described and the samples were stored at −80°C prior to DNA extraction ([@b20-etm-0-0-5778]).

### Extraction of genomic DNA and high-throughput sequencing

Genomic DNA was extracted from each semen sample using a TIANamp Genomic DNA kit (Tiangen Biotech Co., Ltd., Beijing, China) and combined with bead beating as previously described ([@b14-etm-0-0-5778]). The concentration and quality of extracted genomic DNA were tested prior to sequencing using a spectrophotometer at 230 nm (A 260) and 260 nm (A 260) (NanoDrop; Thermo Fisher Scientific, Inc., Waltham, MA, USA). The extracted genomic DNA was used as a template to amplify the V4 region of the 16S rRNA genes of all samples using 515F/806R primers (515F, 5′-GTGCCAGCMGCCGCGGTAA-3′; 806R, 5′-GGACTACVSGGGTATCTAAT-3′). The PCR reaction conditions were as follows: 2 min initial denaturation at 94°C and 30 cycles of 30 sec denaturation at 94°C, 30 sec annealing at 52°C, 30 sec extension at 72°C, followed by a 5 min final extension at 72°C. The samples were maintained at 4°C when the PCR reaction finished. Each 25 µl reaction made up of 2.5 µl 10X *Ex Taq* buffer (Mg^2+^ free; Takara Biotechnology Co., Ltd., Dalian, China), 2 µl (2.5 mM) dNTP mixture, 1.5 µl Mg^2+^ (2.5 mM), 0.25 µl *Ex-Taq* DNA polymerase (Takara Biotechnology Co., Ltd.), 0.5 µl barcode primer V4F (10 µM), 0.5 µl barcode primer V4R252 (10 µM), 2 µl of fecal DNA and 15.75 µl milli-Q water. These PCR products were sequenced using an Illumina HiSeq 2000 platform ([@b21-etm-0-0-5778]).

### Bioinformatics and multivariate statistics

Paired-end reads from the original DNA fragments were merged using FLASH (version 1.2.7; [ccb.jhu.edu/software/FLASH/](ccb.jhu.edu/software/FLASH/)) when any of the reads overlapped that generated from the opposite end of the same DNA fragment. Paired-end reads were assigned to each sample according to the unique barcodes using Trimmomatic (version 0.33) ([@b22-etm-0-0-5778]). Sequence analysis was subsequently performed using the UPARSE software package (version 7.0.100) ([@b23-etm-0-0-5778]) with the UPARSE-OTU and Chao1, the Chao1 estimator and the Shannon index ([@b24-etm-0-0-5778]) with UPARSE-OTUref algorithms. In-house Perl scripts were used to analyze α (within samples) and β (among samples) diversity. Sequences with ≥97% similarity were assigned to the same OTUs. A representative sequence was selected for each OTU and the RDP classifier (version 2.2) ([@b25-etm-0-0-5778]); was used to annotate taxonomic information for each representative sequence. Cluster analysis was preceded by weighted UniFrac distance using QIIME software package (version 1.8.0) ([@b26-etm-0-0-5778]), partial least squares discriminate analysis (PLS-DA) was preceded using SIMCA-P software version 11.5 (Umetrics; Sartorius Stedim Biotech, Malmö, Sweden) and the species that were differentially abundant were characterized for their metabolic capacity using Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt), Version 1.0.0 ([@b27-etm-0-0-5778],[@b28-etm-0-0-5778]). The statistical significance was set at P\<0.05 for correction of multiple comparisons.

Results
=======

### Seminal bacterial composition at phylum level

To compare microbes in the OA and NOA groups, the V4 hypervariable region of bacterial genomic DNA was sequenced using high-throughput sequencing and the effective tags with ≥97% similarity were considered as one OTU. In total, 675,539 usable sequences and 5,867 OTUs were obtained from the samples, with a mean of 345 OTUs per group (data not shown). Furthermore, the Chao1 and Shannon indices were nearly saturated and the rarefaction curve of every sample entered the plateau phase, which indicated that the sequencing data was reasonable (OTU number was sufficient for further analysis) and species composition was highly uniform in each group (data not shown).

At the phylum level, data from the 20 microorganisms that were most abundant in each group was analyzed. Firmicutes, Proteobacteria, Bacteroidetes and Actinobacteria were the predominant phyla, accounting for 98.14% in the C group, 98.26% in the OA group and 90.96% in the NOA group ([Fig. 1A](#f1-etm-0-0-5778){ref-type="fig"}).

Compared with the C group, azoospermia reduced the OTU number of Cyanobacteria, Acidobacteria, Gemmatimonadetes, Planctomycetes, Chloroflexi, Crenarchaeota, Armatimonadetes, Elusimicrobia, Nitrospirae, Euryarchaeota, Spirochaetes, Chlorobi, Synergistetes, Chlamydiae and Verrucomicrobia, whereas the number of Bacteroidetes was increased (P\<0.05; [Fig. 1B](#f1-etm-0-0-5778){ref-type="fig"}).

### Seminal bacterial composition at the genus level

*Lactobacillus*, *Prevotella*, *Proteus*, *Pseudomonas*, *Veillonella*, *Corynebacterium*, *Rhodococcus*, *Staphylococcus* and *Bacillus* were the dominant genera detected in the C (55.02%), OA (62.54%) and NOA (59.74%) groups ([Fig. 2A](#f2-etm-0-0-5778){ref-type="fig"}). The distribution map indicated that *Alicyclobacillus*, *Amaricoccus*, *Anaeromyxobacter*, *Aquicella*, *Arsenicicoccus*, *Azospirillum*, *Chitinimonas*, *Chlorobaculum*, *Coprococcus*, *Desulfovibrio*, *Dokdonella*, *Gallionella*, *Geobacter*, *Helicobacter*, *Idiomarina*, *Kaistia* and *Kribbella* were significantly reduced in the C group compared with the OA and NOA groups (P\<0.05; [Fig. 2B](#f2-etm-0-0-5778){ref-type="fig"}).

### The diversity of the microbial community in the C, OA and NOA groups

There were 1,093, 925 and 840 OTUs detected in the C, OA and NOA groups, respectively ([Fig. 3A](#f3-etm-0-0-5778){ref-type="fig"}). A total of 398 common OTUs were identified in the C, OA and NOA groups, of which 27 belonged to the Lactobacillus phylum ([Fig. 3A](#f3-etm-0-0-5778){ref-type="fig"}). In addition, the partial least squares discriminant analysis (PLS-DA) indicated that patients in the OA and NOA groups scattered on the left, whereas the C group gathered together on the right of the coordinate axis ([Fig. 3B](#f3-etm-0-0-5778){ref-type="fig"}). No overlapping of the C group with the OA or NOA groups was observed; however, some samples in OA and NOA groups overlapped ([Fig. 3B](#f3-etm-0-0-5778){ref-type="fig"}), indicting the microbial diversity between the OA or NOA groups had a higher degree of similarity than the C group.

### Composition of the bacterial communities in C, OA and NOA groups

Significantly more *Sneathia* and *Lysobacter sp*. were present in the NOA group compared with the C and OA groups (P\<0.05; [Fig. 4](#f4-etm-0-0-5778){ref-type="fig"}). The number of *Solibacillus*, *Campyiobacter*, *Campyiobacteraceae* and *Plesiomonas* OTUs in the OA group was significantly higher compared with the NOA and C groups (P\<0.05; [Fig. 4](#f4-etm-0-0-5778){ref-type="fig"}). The number of bacteria in red-labeled genera was significantly higher in the C group compared with the OA and NOA groups (P\<0.05; [Fig. 4](#f4-etm-0-0-5778){ref-type="fig"}).

### Prediction of bacterial functions in C, OA and NOA groups

Correlation analyses were performed for various Kyoto Encyclopedia of Genes and Genomes pathways using the PICRUSt software. The association between seminal bacteria and health was investigated ([Fig. 5A](#f5-etm-0-0-5778){ref-type="fig"}). The results indicated that patients in the OA and NOA groups were at an increased risk of having metabolic, infectious and immune diseases ([Fig. 5A](#f5-etm-0-0-5778){ref-type="fig"}). Furthermore, the results indicate that azoospermia enhances the protein expression of genes associated with nucleotide metabolism, metabolism of cofactors and vitamins, glycan biosynthesis and metabolism, enzyme families and energy metabolism; however, the expression of genes associated with xenobiotic biodegradation and metabolism, metabolism of terpenoids and polyketides, lipid metabolism and amino acid metabolism was downregulated ([Fig. 5B](#f5-etm-0-0-5778){ref-type="fig"}).

Discussion
==========

In the present study, semen samples were obtained from patients with azoospermia and healthy control subjects, following which the 16S rRNA gene fragments were sequenced using high-throughput sequencing method. The results revealed the composition of polymicrobial communities in semen samples and the most prevalent phyla were Firmicutes, Proteobacteria, Bacteroidetes and Actinobacteria, comprising 98.14, 98.26 and 90.96% of total phyla in the C, OA and NOA groups, respectively. Patients in the OA and NOA groups had a greater number of Bacteroidetes and Firmicutes phyla, whereas the number of Proteobacteria and Actinobacteria was decreased compared with the C group. Firmicutes is a phylum of bacteria, the majority of which produce endospores, are resistant to desiccation, are able to survive extreme conditions and are typically found in various environments; this group includes some notable pathogens ([@b29-etm-0-0-5778]). In addition, the phylum Bacteroidetes comprises three large classes of Gram-negative, non-spore-forming, anaerobic or aerobic and rod-shaped bacteria; furthermore, some members of the genus *Bacteroides* are opportunistic pathogens ([@b29-etm-0-0-5778]). The increased number of Bacteroidetes and Firmicutes species in patients with azoospermia may therefore increase the risk of gynecological inflammation in their sexual partners.

At the genus level, nine dominant bacteria of the *Lactobacillus*, *Prevotella*, *Proteus*, *Pseudomonas*, *Veillonella*, *Corynebacterium*, *Rhodococcus, Staphylococcus* and *Bacillus* genera accounted for 55.02, 62.54 and 59.74% of total OTUs in the C, OA and NOA groups, respectively. The OTU number of *Lactobacillus* was 6.79% in the C group, whereas it accounted for 17.98 and 17.24% in the OA and NOA groups, respectively. The vagina and its microflora form a balanced ecosystem; vaginal dysbacteriosis therefore results in obstetric and gynecological diseases, as well as complications characterized by a reduced number or total absence of *Lactobacilli* ([@b30-etm-0-0-5778],[@b31-etm-0-0-5778]). It may therefore be of use to further study the role of *Lactobacillu*s in the semen of patients with azoospermia.

To further compare the microbial diversity across groups, PLS-DA and Venn methods were used. The Venn results indicated that there were 398 OTUs common to the C, OA and NOA groups, of which 27 were *Lactobacillus*. Furthermore, PLS-DA indicated that the bacterial community was more similar when comparing the OA and NOA groups than when comparing either azoospermia group with control subjects. This suggests that sperm may be an important factor in determining microbial composition.

Patients with azoospermia exhibited a reduction in many seminal bacteria compared with healthy controls; however, the OTU number of *Solibacillus*, *Campylobacter*, *Campyiobacteraceae* and *Plesiomonas* in the OA group, as well as *Sneathia* and *Lysobacter* in the NOA group, were increased. The majority of *Campylobacter* species cause diseases that affect humans and other animals, so this increase poses a potential health risk to patients with azoospermia ([@b32-etm-0-0-5778]).

PICRUSt software as used to assess bacterial functions and the results indicated that patients with azoospermia had an increased expression of genes associated with nucleotide metabolism, metabolism of cofactors and vitamins, glycan biosynthesis and metabolism, enzyme families and energy metabolism, as well as a reduced expression of genes associated with xenobiotic biodegradation and metabolism, metabolism of terpenoids and polyketides, lipid metabolism and amino acid metabolism. These changes in expression increase the risk of metabolic, infectious and immune diseases in patients with azoospermia compared with the C group.

In the present study, the seminal bacterial composition in patients with OA and NOA was explored using high-throughput sequencing and the results indicate that the semen of patients with azoospermia contains less beneficial microbes compared with healthy controls. The increased number of Bacteroidetes and Firmicutes species in patients with azoospermia puts them at a greater risk of metabolic, infectious and immune diseases. To the best of our knowledge, this is the first study comparing seminal microbiomes in patients with OA or NOA and healthy men using Illumina sequencing. The small sample size used in the present study may be insufficient to fully reflect the actual microbiota composition of semen from patients with OA or NOA and, as such, future studies are required.
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